M. Hossein Kazemi, MD, medical oncologist and hematologist, Astera Cancer Care, discusses the benefits of de-escalating treatment for patients with multiple myeloma.
It is important the patient with multiple myeloma has a clear and comphrensive understanding of de-escalating treatment, said M. Hossein Kazemi, medical oncologist and hematologist, Astera Cancer Care.
What are the benefits of de-escalating patients?
Right now, in absence of the prospective trials of deciding length of maintenance, based on [minimal residual disease] MRD, right now, one really important factor that I look at is basically, how much of a burden the maintenance is or pressure is on patients’ lives. And especially for elderly patients, even just single agent [lenalidomide] Revlimid, even at lower doses, a lot of times, it's not a completely trivial thing for a patient to take.
Patients still clearly say in terms of energy, how well they are able to digest food. The off week from Revlimid is clearly different from the 3 weeks that they are on. So that's certainly a factor, the quality of life. That’s the main factor for concern.
Also very importantly, that question at some point becomes, if the patient really needs it or not. For example, I had a patient a few months back that has been that had been on maintenance for over 8 years. And we did a bone marrow biopsy, MRD negative, and the patient has come off maintenance and he’s his last clinic visit, he has been very, very happy that he's not taking Revlimid any longer.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More